This means that passive immunization with tau antibodies can be a practical therapeutic concentrate on and the CSF level of p-tau262/356 or on the microtubule binding domain (MTBD) can serve as a useful biomarker of tau pathology to observe tau therapeutics in scientific trials.Through the La Biennale di Venezia Web page: “Her fantastical bodies